These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. A multinational clinical approach to assessing the effectiveness of catheter-based ultrasound renal denervation: The RADIANCE-HTN and REQUIRE clinical study designs. Mauri L; Kario K; Basile J; Daemen J; Davies J; Kirtane AJ; Mahfoud F; Schmieder RE; Weber M; Nanto S; Azizi M Am Heart J; 2018 Jan; 195():115-129. PubMed ID: 29224639 [TBL] [Abstract][Full Text] [Related]
7. [Renal denervation. Current developments]. Saleh A Radiologe; 2013 Mar; 53(3):216-22. PubMed ID: 23503777 [TBL] [Abstract][Full Text] [Related]
8. [Renal denervation for the treatment of resistant hypertension: definition, patient selection and description of the procedure. 2012 Position paper of the Italian Society of Hypertension]. Volpe M; Agabiti-Rosei E; Ambrosioni E; Cottone S; Cuspidi C; Borghi C; De Luca N; Fallo F; Ferri C; Mancia G; Morganti A; Muiesan ML; Sarzani R; Sechi L; Tocci G; Virdis A; G Ital Cardiol (Rome); 2012 Dec; 13(12):846-52. PubMed ID: 23196688 [TBL] [Abstract][Full Text] [Related]
9. [Renal denervation a treatment for resistant hypertension: a French experience]. Benamer H; Mylotte D; Garcia-Alonso C; Unterseeh T; Garot P; Louvard Y; Lefevre T; Morice MC; Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849 [TBL] [Abstract][Full Text] [Related]
10. Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis. Scalise F; Sole A; Singh G; Sorropago A; Sorropago G; Ballabeni C; Maccario M; Vettoretti S; Grassi G; Mancia G J Hypertens; 2020 May; 38(5):936-942. PubMed ID: 31990900 [TBL] [Abstract][Full Text] [Related]
11. Modulation of Sympathetic Overactivity to Treat Resistant Hypertension. Voora R; Hinderliter AL Curr Hypertens Rep; 2018 Sep; 20(11):92. PubMed ID: 30194545 [TBL] [Abstract][Full Text] [Related]
12. Clinical application of interventional renal sympathetic denervation: recommendations of the Austrian Society of Hypertension 2012. Weber T; Zweiker R; Watschinger B; Grüner P; Koppelstätter C; Brandt MC; Horina J; Brussee H; Hohenstein K; Lambert T; Auer J; Hoppe UC Wien Klin Wochenschr; 2012 Nov; 124(21-22):789-98. PubMed ID: 23184070 [TBL] [Abstract][Full Text] [Related]
13. Effect of Catheter-Based Renal Denervation on Morning and Nocturnal Blood Pressure: Insights From SYMPLICITY HTN-3 and SYMPLICITY HTN-Japan. Kario K; Bhatt DL; Brar S; Cohen SA; Fahy M; Bakris GL Hypertension; 2015 Dec; 66(6):1130-7. PubMed ID: 26558819 [TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the Prague-15 study. Rosa J; Widimský P; Toušek P; Petrák O; Čurila K; Waldauf P; Bednář F; Zelinka T; Holaj R; Štrauch B; Šomlóová Z; Táborský M; Václavík J; Kociánová E; Branny M; Nykl I; Jiravský O; Widimský J Hypertension; 2015 Feb; 65(2):407-13. PubMed ID: 25421981 [TBL] [Abstract][Full Text] [Related]
15. Effects of renal sympathetic denervation on blood pressure, sleep apnea course, and glycemic control in patients with resistant hypertension and sleep apnea. Witkowski A; Prejbisz A; Florczak E; Kądziela J; Śliwiński P; Bieleń P; Michałowska I; Kabat M; Warchoł E; Januszewicz M; Narkiewicz K; Somers VK; Sobotka PA; Januszewicz A Hypertension; 2011 Oct; 58(4):559-65. PubMed ID: 21844482 [TBL] [Abstract][Full Text] [Related]
16. [Percutaneous renal denervation as a new method of treatment of resistant arterial hypertension]. Mach-Jamińska A; Sułowicz W Przegl Lek; 2012; 69(11):1215-9. PubMed ID: 23646450 [TBL] [Abstract][Full Text] [Related]
17. [Renal denervation: new treatment for refractory hypertension?]. Argacha JF; Van de Borne P Rev Med Brux; 2012 Sep; 33(4):292-4. PubMed ID: 23091934 [TBL] [Abstract][Full Text] [Related]
18. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. ; Esler MD; Krum H; Sobotka PA; Schlaich MP; Schmieder RE; Böhm M Lancet; 2010 Dec; 376(9756):1903-9. PubMed ID: 21093036 [TBL] [Abstract][Full Text] [Related]
19. Renal sympathetic denervation in patients with treatment-resistant hypertension after witnessed intake of medication before qualifying ambulatory blood pressure. Fadl Elmula FE; Hoffmann P; Fossum E; Brekke M; Gjønnæss E; Hjørnholm U; Kjær VN; Rostrup M; Kjeldsen SE; Os I; Stenehjem AE; Høieggen A Hypertension; 2013 Sep; 62(3):526-32. PubMed ID: 23836798 [TBL] [Abstract][Full Text] [Related]
20. A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients With Resistant Hypertension (RADIOSOUND-HTN). Fengler K; Rommel KP; Blazek S; Besler C; Hartung P; von Roeder M; Petzold M; Winkler S; Höllriegel R; Desch S; Thiele H; Lurz P Circulation; 2019 Jan; 139(5):590-600. PubMed ID: 30586691 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]